Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study

NCT07196436 · View on ClinicalTrials.gov ↗

Study Summary

The primary goal of this study is to investigate the comparative long-term (i.e., 1-year) effectiveness of energy recovery ventilators (ERVs) and portable air cleaners (PACs) in reducing indoor air pollutants and mold levels and improving asthma-related health outcomes in inner-city children and adults with asthma in low-income households in the Dallas-Fort Worth (DFW) metropolitan area, TX. Secondary goals include: (1) examining associations among asthma outcomes, exposure to indoor air pollutants and mold, and housing-related factors, (2) conducting a cost-benefit analysis of ERV and PAC interventions for improving IAQ, mold control, and health outcomes, and (3) evaluating the utility of cost-effective methods and protocols for measuring IAQ and mold for indoor air pollution epidemiology studies and for providing practical information to patients and their physicians. Using a double-blind, placebo-controlled randomized controlled trial, 80 households will be assigned to receive active or placebo versions of ERVs or PACs. Environmental exposures and housing conditions will be monitored alongside comprehensive health assessments, including lung function tests and validated surveys on asthma control, quality of life, stress, and sleep quality.

Interventions

  • DEVICE Energy Recovery Ventilator
  • DEVICE Portable Air Cleaner
  • DEVICE Energy Recovery Ventilator (Sham)
  • DEVICE Portable Air Cleaner (Sham)

Study Locations (2)

Texas

  • University of Texas at Arlington — Arlington
  • Rebuilding Together North Texas — Plano

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-10-10
Est. Completion 2028-02-28
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07196436

The ClinicalTrials.gov registry entry for NCT07196436 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Arlington, which has 73 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 5 conditions, with Stress appearing as the primary indexed condition, and to 4 interventions — of which Energy Recovery Ventilator is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT07196436 reports 2 study locations spanning 1 distinct geographic area — top geographies include Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT07196436 about?

NCT07196436 is a clinical study titled "Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study". The primary goal of this study is to investigate the comparative long-term (i.e., 1-year) effectiveness of energy recovery ventilators (ERVs) and portable air cleaners (PACs) in reducing indoor air pollutants and mold levels and improving asthma-related health outcomes in inner-city children and adu...

What is the current status of trial NCT07196436?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-10-10. Estimated completion is 2028-02-28.

What conditions does trial NCT07196436 study?

This clinical trial studies the following conditions: Stress, Quality of Life, Sleep Quality, Pulmonary Function, Asthma Control. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT07196436?

The interventions under investigation include: Energy Recovery Ventilator (DEVICE), Portable Air Cleaner (DEVICE), Energy Recovery Ventilator (Sham) (DEVICE), Portable Air Cleaner (Sham) (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT07196436?

This trial is sponsored by The University of Texas at Arlington, which has 73 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT07196436 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial